 | • レポートコード：MRC2-11QY03973 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は次世代糖尿病治療・ドラッグデリバリーのグローバル市場について調査・分析したレポートです。種類別（吸入可能型インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓）市場規模、用途別（診断/クリニック、ICU、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別次世代糖尿病治療・ドラッグデリバリーの競争状況、市場シェア ・世界の次世代糖尿病治療・ドラッグデリバリー市場：種類別市場規模 2015年-2020年（吸入可能型インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓） ・世界の次世代糖尿病治療・ドラッグデリバリー市場：種類別市場規模予測 2021年-2026年（吸入可能型インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓） ・世界の次世代糖尿病治療・ドラッグデリバリー市場：用途別市場規模 2015年-2020年（診断/クリニック、ICU、在宅医療） ・世界の次世代糖尿病治療・ドラッグデリバリー市場：用途別市場規模予測 2021年-2026年（診断/クリニック、ICU、在宅医療） ・北米の次世代糖尿病治療・ドラッグデリバリー市場分析：米国、カナダ ・ヨーロッパの次世代糖尿病治療・ドラッグデリバリー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの次世代糖尿病治療・ドラッグデリバリー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の次世代糖尿病治療・ドラッグデリバリー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの次世代糖尿病治療・ドラッグデリバリー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Abbott Laboratories、Medtronic、Sanofi、Novo Nordisk、MannKind Corporation、Enteris BioPharma、Dexcom、Senseonics、Medtech、Synertech、Zosano Pharma、Relmada Therapeutics、Eli Lilly and Company、Transdermal Specialties ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.
The market growth is attributed to the rise in the number of diabetic patients globally and the increase in disposable income among these patients. The benefits of using these advanced devices over conventional products, such as painless mode of insulin delivery and improvement in adherence to medication, and rise in the healthcare expenditure are expected to increase the demand for these products, thus fueling the market growth. However, lack of awareness, cost restrains in the developing regions, and less variability in products are expected to hamper the growth.
Market Analysis and Insights: Global Next Generation Diabetes Therapy and Drug Delivery Market
The global Next Generation Diabetes Therapy and Drug Delivery market size is projected to reach US$ 1812.2 million by 2026, from US$ 1455.9 million in 2020, at a CAGR of 23.3%% during 2021-2026.
Global Next Generation Diabetes Therapy and Drug Delivery Scope and Market Size
Next Generation Diabetes Therapy and Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Next Generation Diabetes Therapy and Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Johnson & Johnson
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind Corporation
Enteris BioPharma
Dexcom
Senseonics
Medtech
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly and Company
Transdermal Specialties
Market segment by Type, the product can be split into
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
Market segment by Application, split into
Diagnostic/Clinics
ICUs
Home Healthcare
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Next Generation Diabetes Therapy and Drug Delivery Revenue
1.4 Market by Type
1.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Inhalable Insulin
1.4.3 Oral Insulin
1.4.4 Insulin Patches
1.4.5 CGM Systems
1.4.6 Artificial Pancreas
1.5 Market by Application
1.5.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic/Clinics
1.5.3 ICUs
1.5.4 Home Healthcare
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Perspective (2015-2026)
2.2 Global Next Generation Diabetes Therapy and Drug Delivery Growth Trends by Regions
2.2.1 Next Generation Diabetes Therapy and Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Next Generation Diabetes Therapy and Drug Delivery Historic Market Share by Regions (2015-2020)
2.2.3 Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Next Generation Diabetes Therapy and Drug Delivery Market Growth Strategy
2.3.6 Primary Interviews with Key Next Generation Diabetes Therapy and Drug Delivery Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Market Size
3.1.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue (2015-2020)
3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2015-2020)
3.1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio
3.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2019
3.3 Next Generation Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
3.4 Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
3.5 Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Type (2015-2020)
4.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
5.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
6.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in North America (2019-2020)
6.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
6.4 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
7 Europe
7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
7.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Europe (2019-2020)
7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
7.4 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
8 China
8.1 China Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
8.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in China (2019-2020)
8.3 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
8.4 China Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
9 Japan
9.1 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
9.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Japan (2019-2020)
9.3 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
9.4 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
10.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
10.4 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
11 India
11.1 India Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
11.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in India (2019-2020)
11.3 India Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
11.4 India Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size (2015-2020)
12.2 Next Generation Diabetes Therapy and Drug Delivery Key Players in Central & South America (2019-2020)
12.3 Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020)
12.4 Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview
13.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Introduction
13.1.4 Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview
13.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Introduction
13.2.4 Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Medtronic
13.3.1 Medtronic Company Details
13.3.2 Medtronic Business Overview
13.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Introduction
13.3.4 Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
13.3.5 Medtronic Recent Development
13.4 Sanofi
13.4.1 Sanofi Company Details
13.4.2 Sanofi Business Overview
13.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Introduction
13.4.4 Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
13.4.5 Sanofi Recent Development
13.5 Novo Nordisk
13.5.1 Novo Nordisk Company Details
13.5.2 Novo Nordisk Business Overview
13.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Introduction
13.5.4 Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
13.5.5 Novo Nordisk Recent Development
13.6 MannKind Corporation
13.6.1 MannKind Corporation Company Details
13.6.2 MannKind Corporation Business Overview
13.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Introduction
13.6.4 MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
13.6.5 MannKind Corporation Recent Development
13.7 Enteris BioPharma
13.7.1 Enteris BioPharma Company Details
13.7.2 Enteris BioPharma Business Overview
13.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Introduction
13.7.4 Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
13.7.5 Enteris BioPharma Recent Development
13.8 Dexcom
13.8.1 Dexcom Company Details
13.8.2 Dexcom Business Overview
13.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Introduction
13.8.4 Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
13.8.5 Dexcom Recent Development
13.9 Senseonics
13.9.1 Senseonics Company Details
13.9.2 Senseonics Business Overview
13.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Introduction
13.9.4 Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
13.9.5 Senseonics Recent Development
13.10 Medtech
13.10.1 Medtech Company Details
13.10.2 Medtech Business Overview
13.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Introduction
13.10.4 Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
13.10.5 Medtech Recent Development
13.11 Synertech
10.11.1 Synertech Company Details
10.11.2 Synertech Business Overview
10.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Introduction
10.11.4 Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
10.11.5 Synertech Recent Development
13.12 Zosano Pharma
10.12.1 Zosano Pharma Company Details
10.12.2 Zosano Pharma Business Overview
10.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Introduction
10.12.4 Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
10.12.5 Zosano Pharma Recent Development
13.13 Relmada Therapeutics
10.13.1 Relmada Therapeutics Company Details
10.13.2 Relmada Therapeutics Business Overview
10.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Introduction
10.13.4 Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
10.13.5 Relmada Therapeutics Recent Development
13.14 Eli Lilly and Company
10.14.1 Eli Lilly and Company Company Details
10.14.2 Eli Lilly and Company Business Overview
10.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Introduction
10.14.4 Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
10.14.5 Eli Lilly and Company Recent Development
13.15 Transdermal Specialties
10.15.1 Transdermal Specialties Company Details
10.15.2 Transdermal Specialties Business Overview
10.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Introduction
10.15.4 Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020)
10.15.5 Transdermal Specialties Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Next Generation Diabetes Therapy and Drug Delivery Key Market Segments
Table 2. Key Players Covered: Ranking by Next Generation Diabetes Therapy and Drug Delivery Revenue
Table 3. Ranking of Global Top Next Generation Diabetes Therapy and Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Inhalable Insulin
Table 6. Key Players of Oral Insulin
Table 7. Key Players of Insulin Patches
Table 8. Key Players of CGM Systems
Table 9. Key Players of Artificial Pancreas
Table 10. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Regions (2015-2020)
Table 14. Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Next Generation Diabetes Therapy and Drug Delivery Market Growth Strategy
Table 20. Main Points Interviewed from Key Next Generation Diabetes Therapy and Drug Delivery Players
Table 21. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Players (2015-2020) (Million US$)
Table 22. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players (2015-2020)
Table 23. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2019)
Table 24. Global Next Generation Diabetes Therapy and Drug Delivery by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
Table 27. Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 30. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Type (2015-2020)
Table 31. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Type (2021-2026)
Table 32. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Application (2015-2020)
Table 33. Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 34. Global Next Generation Diabetes Therapy and Drug Delivery Market Size Share by Application (2021-2026)
Table 35. North America Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 37. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 38. North America Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 39. North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 40. North America Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 41. Europe Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 43. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 45. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 47. China Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 48. China Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 49. China Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 50. China Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 51. China Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 52. China Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 53. Japan Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 55. Japan Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 57. Japan Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 61. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 63. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 65. India Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 66. India Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 67. India Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 68. India Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 69. India Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 70. India Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Next Generation Diabetes Therapy and Drug Delivery Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Next Generation Diabetes Therapy and Drug Delivery Market Share (2019-2020)
Table 73. Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Share by Type (2015-2020)
Table 75. Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Share by Application (2015-2020)
Table 77. Johnson & Johnson Company Details
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Product
Table 80. Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 81. Johnson & Johnson Recent Development
Table 82. Abbott Laboratories Company Details
Table 83. Abbott Laboratories Business Overview
Table 84. Abbott Laboratories Product
Table 85. Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 86. Abbott Laboratories Recent Development
Table 87. Medtronic Company Details
Table 88. Medtronic Business Overview
Table 89. Medtronic Product
Table 90. Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 91. Medtronic Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Product
Table 95. Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 96. Sanofi Recent Development
Table 97. Novo Nordisk Company Details
Table 98. Novo Nordisk Business Overview
Table 99. Novo Nordisk Product
Table 100. Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 101. Novo Nordisk Recent Development
Table 102. MannKind Corporation Company Details
Table 103. MannKind Corporation Business Overview
Table 104. MannKind Corporation Product
Table 105. MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 106. MannKind Corporation Recent Development
Table 107. Enteris BioPharma Company Details
Table 108. Enteris BioPharma Business Overview
Table 109. Enteris BioPharma Product
Table 110. Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 111. Enteris BioPharma Recent Development
Table 112. Dexcom Business Overview
Table 113. Dexcom Product
Table 114. Dexcom Company Details
Table 115. Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 116. Dexcom Recent Development
Table 117. Senseonics Company Details
Table 118. Senseonics Business Overview
Table 119. Senseonics Product
Table 120. Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 121. Senseonics Recent Development
Table 122. Medtech Company Details
Table 123. Medtech Business Overview
Table 124. Medtech Product
Table 125. Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 126. Medtech Recent Development
Table 127. Synertech Company Details
Table 128. Synertech Business Overview
Table 129. Synertech Product
Table 130. Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 131. Synertech Recent Development
Table 132. Zosano Pharma Company Details
Table 133. Zosano Pharma Business Overview
Table 134. Zosano Pharma Product
Table 135. Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 136. Zosano Pharma Recent Development
Table 137. Relmada Therapeutics Company Details
Table 138. Relmada Therapeutics Business Overview
Table 139. Relmada Therapeutics Product
Table 140. Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 141. Relmada Therapeutics Recent Development
Table 142. Eli Lilly and Company Company Details
Table 143. Eli Lilly and Company Business Overview
Table 144. Eli Lilly and Company Product
Table 145. Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 146. Eli Lilly and Company Recent Development
Table 147. Transdermal Specialties Company Details
Table 148. Transdermal Specialties Business Overview
Table 149. Transdermal Specialties Product
Table 150. Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2015-2020) (Million US$)
Table 151. Transdermal Specialties Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Type: 2020 VS 2026
Figure 2. Inhalable Insulin Features
Figure 3. Oral Insulin Features
Figure 4. Insulin Patches Features
Figure 5. CGM Systems Features
Figure 6. Artificial Pancreas Features
Figure 7. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Application: 2020 VS 2026
Figure 8. Diagnostic/Clinics Case Studies
Figure 9. ICUs Case Studies
Figure 10. Home Healthcare Case Studies
Figure 11. Next Generation Diabetes Therapy and Drug Delivery Report Years Considered
Figure 12. Global Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Regions: 2020 VS 2026
Figure 14. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Players in 2019
Figure 17. Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Diabetes Therapy and Drug Delivery as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2019
Figure 19. North America Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Next Generation Diabetes Therapy and Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
糖尿病治療・ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Diabetes Therapy and Drug Delivery Market The global Diabetes Therapy and Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Diabetes Therapy and Drug Delivery Scope and …- インスリン薬・デリバリー技術の世界市場（～2026年） Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along w…
- ドラッグデリバリーシステム（DDS）の世界市場（～2026年） Drug Delivery includes formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredients into the body to safely provide therapeutic effect. Market Analysis and Insights: Global Drug Delivery Systems Market The global Drug Delivery Systems market size is projecte…
- 糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…
- 高度ドラッグデリバリーシステムの世界市場（～2026年） Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted de…